- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 217/12 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
Patent holdings for IPC class C07D 217/12
Total number of patents in this class: 92
10-year publication summary
|
4
|
6
|
9
|
4
|
6
|
7
|
3
|
4
|
1
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Epizyme, Inc. | 374 |
8 |
| Bristol-myers Squibb Company | 4855 |
4 |
| Celgene Quanticel Research, Inc. | 163 |
3 |
| Taisho Pharmaceutical Co., Ltd. | 865 |
3 |
| Toyama Chemical Co., Ltd. | 101 |
3 |
| Antabio SAS | 22 |
2 |
| ConSynance Therapeutics, Inc. | 8 |
2 |
| Enanta Pharmaceuticals, Inc. | 429 |
2 |
| Flexus Biosciences, Inc. | 13 |
2 |
| Georgia State University Research Foundation, Inc. | 348 |
2 |
| Olema Pharmaceuticals, Inc. | 56 |
2 |
| Samumed, LLC | 66 |
2 |
| Wuhan LL Science and Technology Development Co., Ltd | 71 |
2 |
| Techfields Inc | 10 |
2 |
| Lapix Therapeutics, Inc. | 17 |
2 |
| The Regents of the University of California | 20087 |
1 |
| Merck Sharp & Dohme Corp. | 2191 |
1 |
| Janssen Pharmaceutica N.V. | 3362 |
1 |
| Pfizer Inc. | 3375 |
1 |
| Wyeth LLC | 655 |
1 |
| Other owners | 46 |